Literature DB >> 14522000

The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.

L Hu1, T P Wong, S L Côté, K F S Bell, A C Cuello.   

Abstract

A previous study in our laboratory, involving early stage, amyloid pathology in 8-month-old transgenic mice, demonstrated a selective loss of cholinergic terminals in the cerebral and hippocampal cortices of doubly transgenic (APP(K670N,M671L)+PSl(M146L)) mice, an up-regulation in the single mutant APP(K670N,M671L) mice and no detectable change in the PSl(M146L) transgenics [J Neurosci 19 (1999) 2706]. The present study investigates the impact of amyloid plaques on synaptophysin and vesicular acetylcholine transporter (VAChT) immunoreactive bouton numbers in the frontal cortex of the three transgenic mouse models previously described. When compared as a whole, the frontal cortices of transgenic and control mice show no observable differences in the densities of synaptophysin-immunoreactive boutons. An individual comparison of layer V of the frontal cortex, however, shows a significant increase in density in transgenic models. Analysis of the cholinergic system alone shows significant alterations in the VAChT-immunoreactive bouton densities as evidenced by an increased density in the single (APP(K670N,M671L)) transgenics and a decreased density in the doubly transgenics (APP(K670N,M671L)+PSl(M146L)). In investigating the impact of plaque proximity on bouton density at early stages of the amyloid pathology in our doubly (APP(K670N,M671L)+PSl(M146L)) transgenic mouse line, we observed that plaque proximity reduced cholinergic pre-synaptic bouton density by 40%, and yet increased synaptophysin-immunoreactive pre-synaptic bouton density by 9.5%. Distance from plaques (up to 60 microm) seemed to have no effect on bouton density; however a significant inverse relationship was visible between plaque size and cholinergic pre-synaptic bouton density. Finally, the number of cholinergic dystrophic neurites surrounding the truly amyloid, Thioflavin-S(+) plaque core, was disproportionately large with respect to the incidence of cholinergic boutons within the total pre-synaptic bouton population. Confocal and electron microscopic observations confirmed the preferential infiltration of dystrophic cholinergic boutons into fibrillar amyloid aggregates. We therefore hypothesize that extracellular Abeta aggregation preferentially affects cholinergic terminations prior to progression onto other neurotransmitter systems. This is supported by the observable presence of non-cholinergic sprouting, which may be representative of impending neuritic degeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522000     DOI: 10.1016/s0306-4522(03)00394-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Longitudinal brain corticotropin releasing factor and somatostatin in a transgenic mouse (TG2576) model of Alzheimer's disease.

Authors:  Jennifer Horgan; Jose Javier Miguel-Hidalgo; Martha Thrasher; Garth Bissette
Journal:  J Alzheimers Dis       Date:  2007-09       Impact factor: 4.472

2.  Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.

Authors:  Nicole C Berchtold; Marwan N Sabbagh; Thomas G Beach; Ronald C Kim; David H Cribbs; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

Review 3.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

4.  Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence.

Authors:  Karen Hoppens Gylys; Jeffrey A Fein; Fusheng Yang; Dorothy J Wiley; Carol A Miller; Gregory M Cole
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

Authors:  Sylvia E Perez; Bin He; Nadeem Muhammad; Kwang-Jin Oh; Margaret Fahnestock; Milos D Ikonomovic; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2010-10-16       Impact factor: 5.996

6.  BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.

Authors:  Rebecca M Burke; Timothy A Norman; Tarik F Haydar; Barbara E Slack; Susan E Leeman; Jan Krzysztof Blusztajn; Tiffany J Mellott
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

7.  Amyloid-beta expression in retrosplenial cortex of triple transgenic mice: relationship to cholinergic axonal afferents from medial septum.

Authors:  R T Robertson; J Baratta; J Yu; F M LaFerla
Journal:  Neuroscience       Date:  2009-09-20       Impact factor: 3.590

8.  Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Authors:  Sylvia E Perez; Saleem Dar; Milos D Ikonomovic; Steven T DeKosky; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2007-06-27       Impact factor: 5.996

9.  Phenotypic assays for β-amyloid in mouse embryonic stem cell-derived neurons.

Authors:  Laura Beth J McIntire; Natalie Landman; Min Suk Kang; Gina M Finan; Jeremy C Hwang; Ann Z Moore; Lydia S Park; Chyuan-Sheng Lin; Tae-Wan Kim
Journal:  Chem Biol       Date:  2013-07-25

Review 10.  Cholinergic involvement in Alzheimer's disease. A link with NGF maturation and degradation.

Authors:  A Claudio Cuello; Martin A Bruno; Simon Allard; Wanda Leon; M Florencia Iulita
Journal:  J Mol Neurosci       Date:  2009-08-13       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.